High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

被引：0

作者：

Shuhua Yi

Yuting Yan

Meiling Jin

Wenjie Xiong

Zhen Yu

Ying Yu

Rui Cui

Jun Wang

Yi Wang

Yani Lin

Yujiao Jia

Donglei Zhang

Tingyu Wang

Rui Lv

Wei Liu

Weiwei Sui

Wenyang Huang

Mingwei Fu

Yan Xu

Shuhui Deng

Gang An

Dehui Zou

Zengjun Li

Jun Shi

Zhijian Xiao

Jianxiang Wang

Tao Cheng

Robert Peter Gale

Lili Wang

Lugui Qiu

机构：

[1] Chinese Academy of Medical Sciences & Peking Union Medical College,State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology

[2] City of Hope National Comprehensive Cancer Center,Department of Systems Biology, Beckman Research Institute

[3] Tianjin First Center Hospital,Department of Hematology

[4] Imperial College London,Centre for Haematology Research, Department of Immunology and Inflammation

来源：

Leukemia | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2412 / 2415

页数：3

共 50 条

[21] Distinct Clinicopathologic Features of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Based on MYD88 Mutations at Hotspot versus Non-Hotspot Codons
Shuai, Wen
Lin, Pei
Routbort, Mark
Patel, Keyur
Hu, Shimin
Thakral, Beenu
Zhong, Boris
Medeiros, L. Jeffrey
Wang, Wei
LABORATORY INVESTIGATION, 2019, 99
[22] Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
Shuai, Wen
Lin, Pei
Strati, Paolo
Patel, Keyur P.
Routbort, Mark J.
Hu, Shimin
Wei, Peng
Khoury, Joseph D.
You, M. James
Loghavi, Sanam
Tang, Zhenya
Fang, Hong
Thakral, Beenu
Medeiros, L. Jeffrey
Wang, Wei
BLOOD CANCER JOURNAL, 2020, 10 (08)
[23] Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
Wen Shuai
Pei Lin
Paolo Strati
Keyur P. Patel
Mark J. Routbort
Shimin Hu
Peng Wei
Joseph D. Khoury
M. James You
Sanam Loghavi
Zhenya Tang
Hong Fang
Beenu Thakral
L. Jeffrey Medeiros
Wei Wang
Blood Cancer Journal, 10
[24] KMT2D Is a Haploinsufficient Tumor Suppressor in Acute Leukemia
Xu, Jing
Liu, Yu
Chen, Chong
Niu, Ting
BLOOD, 2018, 132
[25] Association of MLL2/KMT2D and MLL3/KMT2C with chronic myeloid leukemia
Rabello Ramos, Doralina do Amaral
da Silva Ferreira, Vivian D'Afonseca
Berzoti-Coelho, Maria Gabriela
Burin, Sandra Mara
Magro, Cintia Leticia
Cacemiro, Maira da Costa
Simoes, Belinda Pinto
Saldanha-Araujo, Felipe
Castro, Fabiola Attie
Pittella-Silva, Fabio
CANCER RESEARCH, 2018, 78 (13)
[26] High-resolution melting analysis for rapid and sensitive MYD88 screening in chronic lymphocytic leukemia (vol 18, pg 814, 2019)
Jiang, Min
Li, Jie
Zhou, Jun
Xing, Chao
Xu, Jing-Jing
Guo, Feng
ONCOLOGY LETTERS, 2019, 18 (03) : 2733 - 2733
[27] Characteristics of epilepsy in patients with Kabuki syndrome with KMT2D mutations
Kurahashi, Naoko
Miyake, Noriko
Mizuno, Seiji
Koshimizu, Eriko
Kurahashi, Hirokazu
Yamada, Keitaro
Natsume, Jun
Aoki, Yusuke
Nakamura, Miho
Taniai, Hiroko
Maki, Yuki
Abe-Hatano, Chihiro
Matsumoto, Naomichi
Maruyama, Koichi
BRAIN & DEVELOPMENT, 2017, 39 (08): : 672 - 677
[28] Dissecting KMT2D missense mutations in Kabuki syndrome patients
Cocciadiferro, Dario
Augello, Bartolomeo
De Nittis, Pasquelena
Zhang, Jiyuan
Mandriani, Barbara
Malerba, Natascia
Squeo, Gabriella M.
Romano, Alessandro
Piccinni, Barbara
Verri, Tiziano
Micale, Lucia
Pasqualucci, Laura
Merla, Giuseppe
HUMAN MOLECULAR GENETICS, 2018, 27 (21) : 3651 - 3668
[29] Absence of KMT2D/MLL2 mutations in abdominal paraganglioma
Bilguvar, Kaya
Goh, Gerald
Korah, Reju
Lifton, Richard P.
Carling, Tobias
CLINICAL ENDOCRINOLOGY, 2016, 84 (04) : 632 - 634
[30] Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia
C Baer
F Dicker
W Kern
T Haferlach
C Haferlach
Leukemia, 2017, 31 : 1355 - 1362

← 1 2 3 4 5 →